News release

Date: 27th September 2011

EPM magazine appoints ELC GROUP as regular contributor

ELC GROUP Advisory Board’s Dr. Paolo Biffignandi to write opinion column for industry leading publication

September 27th 2011 - ELC GROUP, the pan-European pharmaceutical regulatory affairs organisation, announced today that it would be working with the editorial team of European Pharmaceutical Manufacturer magazine to supply expert opinion on the regulatory affairs industry.

ELC GROUP’s Advisory Board member, Dr. Paolo Biffignandi MD, PhD, QPPV, FTOPRA, will write the regular column. Dr. Biffignandi has over 30 years’ experience in Regulatory Affairs and pharmacovigilance. He is a past President and now Fellow of The Organisation for Professionals in Regulatory Affairs (TOPRA) and a renowned physician, with PhDs in endocrinology and pharmacology. He is also an Overseas Fellow of the Royal Society of Medicine (UK).

EPM magazine (European Pharmaceutical Manufacturer) is now in its 11th year of publication and remains the only product tabloid-style publication in the field of pharmaceutical manufacture in Europe. It continues to uphold its reputation as a prime and, most importantly, trusted resource for the global pharmaceutical manufacturing industry by working with industry experts.

Speaking about working with EPM, Marco Rubinstein ELC GROUP CEO said: “We are very excited to be contributing to the market leading publication for the European manufacturing industry. Readers of EPM can expect to gain a real insight into pharmaceutical regulatory affairs thanks to Paolo’s vast experience and industry knowledge.

Editor of EPM Elizabeth Valero said: "I am excited to welcome Paolo on board as the first contributor to EPM's new Regulatory Affairs column. His extensive experience in the field as former President of TOPRA and now as an advisory board member of ELC GROUP made him an ideal candidate. EPM readers can look forward to some very topical and informative submissions from Paolo, the first of which will focus on the impending anti-counterfeiting legislation and what this means for pharma manufacturers."

The first column written by Paolo will appear in the October edition of EPM. For a free subscription to the magazine and to read all future Regulatory Affairs columns written by Paolo, please click here (http://www.epmmagazine.com/x/subscriberNew.html).


Press contacts
Akhil Jain

ELC Group
ajain [at] elc-group [dot] com
Phone: +420 22 491 00 00

Miranda Rock
EvokedSet PR
miranda [at] evokedset [dot] com
Phone: +44 (0)7957 391 498

Elizabeth Valero
Editor, European Pharamceutial Manufacturer
Ellie [at] rapidnews [dot] com
Phone +44 (0)1829 770037

About ELC Group (www.elc-group.com)
ELC GROUP is a leading global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries as well as REACH services to the Chemical industry. ?It helps companies that lack the resource (skills and knowledge) to cost effectively deliver regulatory affairs.

ELC Group provides full-service, multi-lingual consulting and cost-effective solutions to regulatory approvals using experts with in-depth knowledge and experience throughout the world. The team ranges from former FDA investigators to individuals with over 30 years of industry experience with broad capabilities. This includes integrated advanced technologies, regulatory affairs consulting and commercialisation services.



Close This Window